ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients
Authors
Keywords
-
Journal
LEUKEMIA
Volume 28, Issue 11, Pages 2206-2212
Publisher
Springer Nature
Online
2014-04-03
DOI
10.1038/leu.2014.125
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological review
- (2014) Mrinal M. Patnaik et al. BRITISH JOURNAL OF HAEMATOLOGY
- ASXL1 but Not TET2 Mutations Adversely Impact Overall Survival of Patients Suffering Systemic Mastocytosis with Associated Clonal Hematologic Non-Mast-Cell Diseases
- (2014) Gandhi Damaj et al. PLoS One
- Comprehensive mutational profiling in advanced systemic mastocytosis
- (2013) J. Schwaab et al. BLOOD
- Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
- (2013) Raphaël Itzykson et al. JOURNAL OF CLINICAL ONCOLOGY
- SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias
- (2013) F Damm et al. LEUKEMIA
- SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML
- (2013) R R Laborde et al. LEUKEMIA
- U2AF1 mutations in primary myelofibrosis are strongly associated with anemia and thrombocytopenia despite clustering with JAK2V617F and normal karyotype
- (2013) A Tefferi et al. LEUKEMIA
- Mutations and prognosis in primary myelofibrosis
- (2013) A M Vannucchi et al. LEUKEMIA
- Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes
- (2013) M M Patnaik et al. LEUKEMIA
- SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations
- (2013) M Meggendorfer et al. LEUKEMIA
- SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)
- (2012) M. Meggendorfer et al. BLOOD
- SRSF2 mutations in primary myelofibrosis: significant clustering with IDH mutations and independent association with inferior overall and leukemia-free survival
- (2012) T. L. Lasho et al. BLOOD
- Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
- (2012) Véronique Gelsi-Boyer et al. Journal of Hematology & Oncology
- ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome
- (2012) S Schnittger et al. LEUKEMIA
- Recurrent SETBP1 mutations in atypical chronic myeloid leukemia
- (2012) Rocco Piazza et al. NATURE GENETICS
- Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
- (2012) Jay P. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value
- (2011) M. M. Patnaik et al. BLOOD
- Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia
- (2011) Y. Shen et al. BLOOD
- ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category
- (2011) K. H. Metzeler et al. BLOOD
- Prognostic Significance of ASXL1 Mutations in Patients With Myelodysplastic Syndromes
- (2011) Felicitas Thol et al. JOURNAL OF CLINICAL ONCOLOGY
- Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms
- (2011) O Abdel-Wahab et al. LEUKEMIA
- Frequent pathway mutations of splicing machinery in myelodysplasia
- (2011) Kenichi Yoshida et al. NATURE
- Clinical Effect of Point Mutations in Myelodysplastic Syndromes
- (2011) Rafael Bejar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytogenetic risk stratification in chronic myelomonocytic leukemia
- (2010) E. Such et al. HAEMATOLOGICA
- The most commonly reported variant in ASXL1 (c.1934dupG;p.Gly646TrpfsX12) is not a somatic alteration
- (2010) O Abdel-Wahab et al. LEUKEMIA
- Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
- (2010) A Tefferi LEUKEMIA
- Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia
- (2010) J Boultwood et al. LEUKEMIA
- Mutations of polycomb-associated geneASXL1in myelodysplastic syndromes and chronic myelomonocytic leukaemia
- (2009) Véronique Gelsi-Boyer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias
- (2009) N Carbuccia et al. LEUKEMIA
- Mutations of ASXL1 gene in myeloproliferative neoplasms
- (2009) N Carbuccia et al. LEUKEMIA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started